| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0001 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -7.3e-05 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -5.3e-05 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 2e-05 | 1 |